3 Top Undervalued Small Caps In United States With Insider Activity

In this article:

Over the last 7 days, the market has remained flat. As for the longer term, the market has risen 32% in the past 12 months and earnings are forecast to grow by 15% annually. In this environment, identifying undervalued small-cap stocks with insider activity can present unique opportunities for investors looking to capitalize on potential growth.

Top 10 Undervalued Small Caps With Insider Buying In The United States

Name

PE

PS

Discount to Fair Value

Value Rating

Columbus McKinnon

22.1x

1.0x

39.87%

★★★★★☆

Thryv Holdings

NA

0.7x

26.33%

★★★★★☆

Citizens & Northern

12.9x

2.9x

43.78%

★★★★☆☆

MYR Group

34.1x

0.5x

42.61%

★★★★☆☆

Franklin Financial Services

9.8x

1.9x

39.21%

★★★★☆☆

German American Bancorp

13.9x

4.6x

46.75%

★★★☆☆☆

Community West Bancshares

18.7x

2.9x

42.25%

★★★☆☆☆

Orion Group Holdings

NA

0.3x

-102.15%

★★★☆☆☆

Sabre

NA

0.5x

-72.61%

★★★☆☆☆

Delek US Holdings

NA

0.1x

-220.20%

★★★☆☆☆

Click here to see the full list of 54 stocks from our Undervalued US Small Caps With Insider Buying screener.

Let's review some notable picks from our screened stocks.

Columbus McKinnon

Simply Wall St Value Rating: ★★★★★☆

Overview: Columbus McKinnon is a company specializing in the design, manufacturing, and marketing of material handling products and systems with a market cap of approximately $1.34 billion.

Operations: The company generates revenue primarily from its Machinery & Industrial Equipment segment, amounting to $1.02 billion. The gross profit margin has shown an upward trend, reaching 37.08% in the latest period ending September 2024. Operating expenses include significant allocations to sales and marketing ($108.13 million) and general & administrative expenses ($105.42 million).

PE: 22.1x

Columbus McKinnon, a smaller U.S. company, is currently undervalued with earnings forecasted to grow nearly 30% annually. Despite net income dipping slightly to US$8.63 million in Q1 2024 from US$9.28 million the previous year, insider confidence is evident as executives have shown interest in share purchases recently. The company projects modest sales growth for fiscal 2025 and maintains a quarterly dividend of US$0.07 per share, highlighting its commitment to returning value to shareholders amidst leadership changes and strategic adjustments.

NasdaqGS:CMCO Share price vs Value as at Sep 2024
NasdaqGS:CMCO Share price vs Value as at Sep 2024

MaxLinear

Simply Wall St Value Rating: ★★★★☆☆

Overview: MaxLinear is a company specializing in the design and production of semiconductors with a market cap of $2.50 billion.

Operations: MaxLinear's primary revenue stream is from its semiconductor segment, which generated $448.14 million. The company's gross profit margin was 53.99%, with significant operating expenses including R&D at $252.86 million and general & administrative costs at $129.87 million for the latest reporting period ending 2024-09-26.

PE: -6.8x

MaxLinear, a U.S. small-cap stock, has recently garnered attention due to significant insider confidence, with CEO Kishore Seendripu purchasing 108,303 shares valued at approximately US$1.4 million between July and August 2024. The company showcased its Panther III storage accelerator at multiple conferences in August and September 2024, highlighting substantial cost savings and performance improvements over traditional solutions. Despite reporting a net loss of US$39 million for Q2 2024, MaxLinear's innovative product offerings position it well for future growth in the expanding data storage market.

NasdaqGS:MXL Share price vs Value as at Sep 2024
NasdaqGS:MXL Share price vs Value as at Sep 2024

Varex Imaging

Simply Wall St Value Rating: ★★★★☆☆

Overview: Varex Imaging specializes in manufacturing X-ray imaging components for medical and industrial applications, with a market cap of approximately $0.78 billion.

Operations: Varex Imaging generates revenue primarily from its Medical and Industrial segments, with recent figures showing $601 million and $231.7 million respectively. The company experienced fluctuations in net income margin, reaching 5.40% as of September 2023 after previously recording negative margins in 2020 and early 2021. Gross profit margin has varied over the years, most recently at 32.49%.

PE: 14.1x

Varex Imaging, a smaller company in the medical imaging sector, has recently seen insider confidence with CFO Shubham Maheshwari purchasing 10,000 shares worth US$108,200. Despite being dropped from several S&P indices on September 7, 2024, Varex reported Q3 sales of US$209.1 million and net income of US$1.4 million. However, earnings have declined compared to the previous year. The company's earnings are projected to grow by 16.15% annually but face challenges with high-risk funding sources and insufficient coverage of interest payments by earnings.

NasdaqGS:VREX Share price vs Value as at Sep 2024
NasdaqGS:VREX Share price vs Value as at Sep 2024

Next Steps

Seeking Other Investments?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NasdaqGS:CMCO NasdaqGS:MXL and NasdaqGS:VREX.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Advertisement